Next-Gen Biologics Lead Healthcare InnovationThe Biologic Therapeutic Drug Market has emerged as one of the most ...

Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a blockbuster, appears to have led to a dramatic drop in net spending for these ...

SEATTLE--(BUSINESS WIRE)--Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the closing of a $16 million Series B ...

April 22 saw a wave of AI-related developments, from TSMC unveiling next-generation semiconductor processes to biotech ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.

New biologic drugs for chronic obstructive pulmonary disease (COPD) are finally here, said Stephen Rennard, MD, in a presentation in a session on new drugs at the 2024 GOLD International COPD ...

BOSTON – Hao Zhu, director of the Division of Pharmacometrics in the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) said the number of drug applications ...

Biointron, an antibody contract research organization, launched a new developability platform that helps drug developers identify manufacturing problems early, potentially saving millions by catching ...

Biologic medicines are making inroads into chronic obstructive pulmonary disease (COPD), with two blockbuster antibodies expanding their FDA-approved uses to this lung disorder in the past year. A ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the ...

The MarketWatch News Department was not involved in the creation of this content.-- Free-to-attend event takes place at Pfizer in Cambridge, MA from 16--17 June -- Drug Discovery ...

The International Council for Harmonisation (ICH) on Wednesday advanced a questions and answers guideline aimed at clarifying expectations for selecting and justifying starting materials for drug and ...